Unicycive Therapeutics, Inc. (UNCY) News
Track canonical SquawkNews coverage tagged to UNCY, Unicycive Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 15 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Unicycive Therapeutics Posts Q2 2026 Results
Unicycive Therapeutics announces second quarter 2026 financial results
EARNINGS | Aug 12, 2026, 11:19 AM UTC
H
Kalshi Will Let Traders Bet on FDA Drug Approvals Despite Critics' Insider Trading Warnings
Prediction market platform Kalshi is expanding into biotech, launching contracts Wednesday night that let traders bet on clinical trial outcomes and drug approvals from companies including Sanofi (NASDAQ: SNY ) and Gilea
REGULATION | Jul 16, 2026, 05:29 PM UTC
L
Unicycive Therapeutics ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses
Boston, Massachusetts--(. - July 6, 2026) - Block & Leviton is investigating Unicycive Therapeutics, Inc. (NASDAQ: UNCY) for potential securities law violations. Investors who have lost mo
EQUITY | Jul 06, 2026, 12:43 PM UTC
L
Benchmark Maintains Speculative Buy on Unicycive Therapeutics, Lowers Price Target to $13
Benchmark analyst Bruce Jackson maintains Unicycive Therapeutics (NASDAQ: UNCY ) with a Speculative Buy and lowers the price target from $18 to $13.
EQUITY | Jul 01, 2026, 03:33 PM UTC
L
Noble Capital Markets Maintains Outperform on Unicycive Therapeutics, Lowers Price Target to $50
Noble Capital Markets analyst Robert LeBoyer maintains Unicycive Therapeutics (NASDAQ: UNCY ) with a Outperform and lowers the price target from $60 to $50.
EQUITY | Jul 01, 2026, 01:51 PM UTC
L
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Alzamend Neuro (NASDAQ: ALZN ) stock increased by 12.9% to $1.35 during Tuesday's after-market session. The company's market cap stands at $4.4 million. Vivos Therapeutics (NASDAQ: VVOS ) shares increased by 9.92
GEOPOLITICS | Jun 30, 2026, 09:05 PM UTC
L
HC Wainwright & Co. Maintains Buy on Unicycive Therapeutics, Lowers Price Target to $15
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Unicycive Therapeutics (NASDAQ: UNCY ) with a Buy and lowers the price target from $22 to $15.
EQUITY | Jun 30, 2026, 05:29 PM UTC
L
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Creative Medical Tech (NASDAQ: CELZ ) stock moved upwards by 242.5% to $2.77 during Tuesday's regular session. The market value of their outstanding shares is at $2.9 million. Cuprina Holdings (Cayman) (NASDAQ: C
EQUITY | Jun 30, 2026, 05:05 PM UTC
L
B. Riley Securities Maintains Buy on Unicycive Therapeutics, Maintains $22 Price Target
B. Riley Securities analyst Mayank Mamtani maintains Unicycive Therapeutics (NASDAQ: UNCY ) with a Buy and maintains $22 price target.
EQUITY | Jun 30, 2026, 05:01 PM UTC
L
Nasdaq Gains Over 300 Points; Chicago PMI Falls In June
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 300 points on Tuesday. The Dow traded up 0.28% to 52,327.93 while the NASDAQ rose 1.31% to 26,157.23. The S&P 500 also rose, gainin
MACRO | Jun 30, 2026, 04:08 PM UTC
L
Why Is Unicycive Therapeutics Stock Falling Tuesday?
Unicycive Therapeutics, Inc. (NASDAQ: UNCY ) on Monday said the U.S. Food and Drug Administration has issued a Complete Response Letter (CRL) for its resubmitted New Drug Application (NDA) seeking approval of oxylanthanu
GEOPOLITICS | Jun 30, 2026, 03:04 PM UTC
L
US Stocks Mixed; Home Prices Increase 1.1% In April
U.S. stocks traded mixed this morning, with the Dow Jones index falling around 0.2% on Tuesday. Following the market opening Tuesday, the Dow traded down 0.18% to 52,091.03 while the NASDAQ rose 0.36% to 25,912.25. The S
RATES | Jun 30, 2026, 01:47 PM UTC
H
Select Premarket Movers
Upside: -AVAV +35% (earnings, guidance) -VWAV +29% (acquires 51% controlling interest in private Israeli aerospace and defense company Meteor Aerospace for ~$20.4M in stock) -SEDG +11% (solar stock strength following FCC
GEOPOLITICS | Jun 30, 2026, 12:26 PM UTC
L
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Abivax (NASDAQ: ABVX ) shares increased by 36.0% to $130.74 during Tuesday's pre-market session. The company's market cap stands at $7.6 billion. Cuprina Holdings (Cayman) (NASDAQ: CUPR ) shares moved upwards by
EQUITY | Jun 30, 2026, 12:05 PM UTC
M
Unicycive Therapeutics Receives FDA Complete Response Letter On Its Application For Oxylanthanum Carbonate For Hyperphosphatemia In Patients
Unicycive Therapeutics, Inc. (NASDAQ: UNCY ), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that it has received a Complete Response Letter (CRL) from the U
REGULATION | Jun 30, 2026, 11:10 AM UTC